SIDCapital

Potential LONG For Abbott Stock

Long
CURRENCYCOM:ABT   None
In its latest earnings report, released on 03/31/2020, Abbott reported a quarterly revenue of $7.73 billion and a net profit of $758 million. Abbott Laboratories is expected to post earnings per share (EPS) of $0.32 for the third quarter of 2020.

Key Trading Plan:

Wait for pull back to the support level of 92.25 before the price eventually rallies up to the Take Profit Target level of 100.29. The upside movement is still strong, hence any SHORT position is kinda risky to take at the moment.



‼️Disclaimer: Please be advised that we are NOT Financial Advisors. We are not responsible for the results of your Forex or CFDs trading. The only person responsible for profits or losses is yourself. You should not consider any market information, educational and analytical material as trading advice that defines your trading actions but purely as educational market material. Please be advised that S.I.D. Capital shall not be liable for any errors in quotes and trading platform software errors.

‼️This Channel and all information is intended for educational purposes only and does not give financial advice. S.I.D. Capital Signals is not a service to provide legal and financial advice; any information provided here is only the personal opinion of the author (not advice or financial advice in any sense, and in the sense of any act, ordinance or law of any country) and must not be used for financial activities.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.